Friday 6 November 2026 Export BIO’s income statement to Excel — free account

Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.6 billion, up 0.65% from fiscal 2024.

Revenue: +0.52%
EPS: +234.8%
Free cash flow: +8.07%
Total debt: +0.11%

Quarter to September 2026, against a year earlier

Operating cash flow growth 3 yrs

382.51 13.51 +3.66%

Follow BIO

Alert me

Market cap: $9.9B
P/E: 10.0×
Fwd P/E: 44.7×
Dividend yield: —
F-score: 5/9
Altman Z: 3.20
Beneish M: −2.29
Dividend safety: n/a

Overview Business Profile Earnings & Analysis Segments Valuation Filings

Bio-Rad Laboratories, Inc. (BIO) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Bio-Rad Laboratories, Inc. (BIO) trades at a P/E ratio of 10.0×. Over the past ten years it has ranged from 0.0× (December 2025) to 466× (August 2017); the current reading is higher than 55% of that period. That is below the Medical Devices industry median of 25.6× and below the Healthcare sector median of 25.2×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/BIO/pe-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Bio-Rad Laboratories, Inc. P/E ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/BIO/metrics/pe-ratio">Bio-Rad Laboratories, Inc. (BIO) P/E ratio — stockrow.com</a></p>

Period	P/E ratio	Change
FY2025	10.8×	—
FY2024	0.0×	—
FY2023	0.0×	—
FY2022	0.0×	—
FY2021	5.3×	16.25%
FY2020	4.6×	(27.43%)
FY2019	6.3×	(67.07%)
FY2018	19.1×	(69.52%)
FY2017	62.5×	(67.17%)
FY2016	191×	431.77%

Period	P/E ratio	Change
Sep 2026	9.9×	(71.91%)
Jun 2026	35.2×	(22.74%)
Mar 2026	45.6×	320.85%
Dec 2025	10.8×	—
43 more quarters	Free account

Against its own ten years

Low 0.0× High 466×

Ten-year median 8.6×

Current reading's percentile 40

Company	P/E ratio
BRKR Bruker Corporation compare	n/m
GKOS Glaukos Corporation compare	n/m
TXG 10x Genomics compare	n/m
BIO Bio-Rad Laboratories, Inc.	9.7×
BIO.B Bio-Rad Laboratories, Inc. compare	9.9×
GMED Globus Medical, Inc. compare	19.5×
PODD Insulet Corporation compare	25.2×
SNN Smith & Nephew SNATS, Inc. compare	38.9×
PEN Penumbra, Inc. compare	80.3×
Medical Devices industry median	25.6×
Healthcare sector median	25.2×
Market median	17.9×

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

Bio-Rad Laboratories, Inc. (BIO) P/E ratio

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BIO

P/E ratio, daily

Annual newest first

Quarterly newest first

Against its own ten years

P/E ratio against peers

What P/E ratio is

More on BIO

Stockrow Weekly